Usami, Masahide
Sasaki, Yoshinori
Ichikawa, Mayuna
Matsudo, Miki
Hashimoto, Ayaka
Kusanish, Shun
Kato, Nobutada
Makiyama, Ryuwa
Ohashi, Mutsumi
Higashino, Yui
Kono, Yusuke
Matsudo, Haruna
Ma, Minjae
Sakoh, Yuuki
Odaka, Maiko
Itagaki, Kotoe
Yamamoto, Keita
Takahashi, Momoka
Yoshimura, Yuta
Inoue, Saori
Ishida, Masahiro
Ito, Masaya
Mikami, Katsunaka
Tsujii, Noa
Kihara, Hiroaki
Inazaki, Kumi
Hakoshima, Yuki
Mizumoto, Yuki
Funding for this research was provided by:
the Health Labor Sciences Research Grant (23GC0013)
Japan Institute for Health Security (24A1014)
Article History
Received: 13 September 2025
Accepted: 19 January 2026
First Online: 4 February 2026
Declarations
:
: Katsunaka Mikami has received honoraria from Shionogi & Co., Ltd., SumitomoPharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Lundbeck Japan K.K., and OtsukaPharmaceutical Co., Ltd., and a consulting fee from Shionogi & Co., Ltd, EA PharmaCo., Ltd., Sumitomo Pharma Co., Ltd. and Otsuka Pharmaceutical Co., Ltd. The otherauthors declare no competing interests.